Jeffrey M Gelfand
Affiliation: University of California
- Multiple sclerosis: diagnosis, differential diagnosis, and clinical presentationJeffrey M Gelfand
Department of Neurology, University of California, San Francisco, USA Electronic address
Handb Clin Neurol 122:269-90. 2014....
- Microcystic inner nuclear layer abnormalities and neuromyelitis opticaJeffrey M Gelfand
Multiple Sclerosis Center, Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA
JAMA Neurol 70:629-33. 2013..Acute optic neuritis is a cardinal manifestation of neuromyelitis optica (NMO). To our knowledge, microcystic inner nuclear layer abnormalities have not been investigated in NMO...
- Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypesJeffrey M Gelfand
University of California, San Francisco Department of Neurology, Multiple Sclerosis Center, University of California San Francisco, San Francisco, California, United States of America
PLoS ONE 7:e36847. 2012....
- Fingolimod treatment in multiple sclerosis leads to increased macular volumeRachel Nolan
Multiple Sclerosis Center, UCSF Department of Neurology, San Francisco, CA, USA
Neurology 80:139-44. 2013..To determine whether fingolimod, an oral sphingosine-1-phosphate receptor modulator approved for treatment of multiple sclerosis (MS), generally leads to increased retinal tissue volume...
- Microcystic macular oedema in multiple sclerosis is associated with disease severityJeffrey M Gelfand
Multiple Sclerosis Centre, University of California, San Francisco, Department of Neurology, 400 Parnassus Ave, San Francisco, CA 94143 0114, USA
Brain 135:1786-93. 2012..These findings also have implications for clinical monitoring in patients with multiple sclerosis on sphingosine 1-phosphate receptor modulating agents...
- Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective studyShiv Saidha
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Lancet Neurol 11:963-72. 2012..We aimed to determine whether MMO of the INL, and increased thickness of the INL are associated with disease activity or disability progression...